Johnson & Johnson (JNJ) Tops Q1 EPS by 6c

(Updated - April 16, 2019 6:43 AM EDT)

Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.10, $0.06 better than the analyst estimate of $2.04. Revenue for the quarter came in at $20.02 billion versus the consensus estimate of $19.61 billion.

GUIDANCE:

Johnson & Johnson sees FY2019 EPS of $8.53-$8.63, versus the consensus of $8.58. Johnson & Johnson sees FY2019 revenue of $80.4-81.2 billion, versus the consensus of $81.05 billion.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.

You May Also Be Interested In

• Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
• Bernstein upgrades Analog Devices on Q3 beat, improving risk-reward
• Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance